Skip to Content Facebook Feature Image

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy

Business

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy
Business

Business

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy

2026-01-08 10:41 Last Updated At:11:05

SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of operation, the company is formally transitioning from a Radiofrequency Ablation (RFA) specialist into a global multi-modality medical technology platform.

Established in 2009, STARMED pioneered the first thyroid-dedicated RFA electrode, effectively creating a clinical field that did not previously exist. This technology has since been adopted into various international clinical guidelines and continues to maintain the leading global market share today. Building on this heritage, STARMED has expanded its portfolio to address diverse clinical needs in liver, uterine, and vascular care, introducing various products such as the proprietary multi-electrode Octopus system. The current rebranding signals a strategic commitment to expand beyond RFA by integrating diverse energy sources, including Microwave Ablation (MWA) and Irreversible Electroporation (IRE), into a unified therapeutic offering.

"With the global thermal ablation market projected to reach $2 billion by 2033, this rebranding is a pivotal step for our next stage of growth," said CEO Henry Shin.

The newly unveiled Corporate Identity reflects both STARMED's heritage and its future vision. The symbol represents technical precision by visualising the initial 'S' alongside the silhouette of an electrode tip. This reflects a dedication to minimising patient pain and providing care throughout the recovery process. The wordmark employs a sophisticated, futuristic typeface to reinforce trust within the global healthcare arena.

Supported by strong financial foundations, STARMED plans to capitalise on a market growing at 10.5% annually. The company remains committed to establishing minimally invasive treatments as the global 'Standard of Care' through enhanced clinical partnerships.

About STARMED

STARMED is a medical device specialist founded in 2009. With more than 660 clinical research evidence, the company provides world-class thermal ablation solutions to over 70 countries and continues to advance minimally invasive treatment as the clinical standard.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy

LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- Guide Sensmart (Booth 21740, Central Hall), a global leader in thermal imaging technology, officially launched its next-generation thermal imaging innovation – ApexVision – alongside a series of new products empowered by the technology. This launch represents a systemic leap for the industry from merely "seeing heat" to "seeing with clarity, precision, and intelligence," marking the dawn of a new era defined by Ultra-Clarity.

CES Show Floor Reaction: "Ultra-Clarity" Draws Deep Engagement

At the Guide Sensmart booth, live product demonstrations powered by ApexVision attracted strong attention from industry analysts to global media. Hands-on comparisons—such as maintaining clear imaging details of distant targets and delivering crisp, smear-free imaging of fast-moving objects—earned consistent praise. Many professional visitors noted that this reliable "what-you-see-is-what-you-get" clarity would directly enhance operational efficiency and decision-making confidence.

ApexVision integrating both hardware and software: It combines the high-sensitivity ApexCore S1 detector, the Nexus 1.0 processing platform, and scenario-optimized algorithms. Together, ApexVision successfully overcomes persistent challenges such as low contrast in complex environments, detail loss at long range or high magnification, motion blur on fast-moving objects, and inaccurate detection of minute temperature differences.

From Architecture to Application: A Full Portfolio Empowered

On the CES show floor, Guide Sensmart demonstrated how ApexVision delivers tangible improvements across thermal devices. Thermography tools (e.g. E3S, H6S thermal cameras) leverage the SharpIR 2.0 algorithm to provide stable, accurate temperature measurement in demanding environments, enabling inspectors to pinpoint hidden faults with greater confidence. Outdoor hunting optics (e.g. TD650LS monocular and TN650MS binocular), benefit from Hyper-Light 2.0, allowing users to identify nocturnal wildlife in complete darkness and track fast-moving targets while maintaining clean, sharp images even at 10× zoom.

"The launch of ApexVision marks a milestone where our vertically integrated technology development translates into real value for users," said a Guide Sensmart spokesperson. "It is more than a set of specifications—it delivers the certainty of Ultra-Clarity to every professional user."

The debut of ApexVision at CES 2026 signifies more than a routine product update. By resolving long-standing trade-offs between sensitivity, stability, and environmental robustness, Guide Sensmart is advancing thermal imaging into the Ultra-Clarity Era, building a clearer, safer, and more efficient future.

We are keen to explore partnership of collaboration with you. Know more about Guide Sensmart at https://www.guideir.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

ApexVision Debuts at CES 2026: Guide Sensmart Ushers in the Ultra-Clarity Era of Thermal Imaging

ApexVision Debuts at CES 2026: Guide Sensmart Ushers in the Ultra-Clarity Era of Thermal Imaging

Recommended Articles